A blood test for detecting cancer early being developed by the diagnostics firm Grail failed to meet its main goal in a giant ...

The top drug regulator at the FDA told staff she plans to question the safety of taking SSRIs in pregnancy and of RSV shots ...

Rick Abrmason, formerly a chief medical officer at a subsidiary of Harrison.ai, which develops AI products to interpret ...

Federal officials have missed the legal deadline to notify the public of an upcoming ACIP meeting, raising questions about ...

After years of grand ambitions, the federal government disclosed that it is months away from rolling out a centralized list ...

Dr. Oz said your poop “should gently hit the water like Greg Louganis diving in.” In other news, the Potomac, threatened by ...

I took part in a 2012 psilocybin trial. What I’m seeing now horrifies me,” writes Erica Rex, author of the new book “Seeing ...

Some GLP-1 patients are begging to stay on the drugs just a little bit longer, presenting an ethical dilemma for doctors.

Was Hims' Super Bowl ad the final straw for regulators? Is the bar being lowered for psychedelic medicines? And what's happening with Moderna and FDA? Find out on "The Readout LOUD" podcast.

Hims & Hers is buying the Australian telehealth firm Eucalyptus as it looks to make inroads in more countries globally.

HHS has elevated a new team of health policy experts, including a former health IT exec and a Trump administration veteran.

FDA Commissioner Marty Makary said he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring ...